Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Sell
2,474
-72
-3% -$8.43K 0.02% 508
2026
Q1
$306K Buy
+2,546
New +$294K 0.02% 463
2023
Q4
Sell
-2,284
Closed -$235K 359
2023
Q3
$235K Buy
2,284
+465
+26% +$50.1K 0.04% 234
2023
Q2
$210K Buy
+1,819
New +$207K 0.04% 213
2022
Q4
Sell
-5,627
Closed -$485K 197
2022
Q3
$485K Buy
5,627
+3
+0.1% +$268 0.13% 23
2022
Q2
$513K Buy
+5,624
New +$499K 0.14% 24
2021
Q1
Sell
-210
Closed -$16K 479
2020
Q4
$16K Buy
+210
New +$16.1K 0.01% 457

Other funds holding MRK

Inspire Advisors's MRK Position: Q2 2026 in Review

Inspire Advisors reduced its Merck (MRK) stake by 2.8% in Q2 2026, selling an estimated $8.43K and leaving 2,474 shares worth $316K. The position accounts for 0.02% of the portfolio, ranked #508.

Inspire Advisors first reported a position in MRK in Q4 2020 and has held it in 7 quarters since. The position peaked at $513K in Q2 2022. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Inspire Advisors held 2,474 shares of Merck worth $316K as of Q2 2026.
  • Inspire Advisors sold 72 Merck shares in Q2 2026, an estimated $8.43K.
  • Merck made up 0.02% of Inspire Advisors's portfolio in Q2 2026, its #508 holding.
  • Inspire Advisors first reported a position in Merck in Q4 2020 and has held it in 7 quarters since.
  • Inspire Advisors's Merck position peaked at $513K in Q2 2022.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.